About
John Schloendorn is a biotech founder and longevity-sector operator focused on gene, cell, and regenerative medicine. Public biographies describe him as founder and CEO of Gene and Cell Technologies, former CEO of venture-backed ImmunePath, and former Director of SENS Foundation's intramural Research Center. In 2026, WIRED identified him as a cofounder of R3 Bio, and he has also appeared publicly as an advisor to X-Therma and on BioViva's advisory board.
Areas of interest
longevitybiotechregenerative medicinegene therapycell therapyorgan engineeringcryopreservation